ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ENTX vs DBVT // NET PROFIT MARGIN

Entera Bio Ltd. (NASDAQ) VS. DBV Technologies S.A. (NASDAQ) • 15-METRIC TALLY: ENTX 3 — DBVT 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ENTX VS. DBVT) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ENTX DBVT SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 0.00% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -33.60% -35.00% +1.40 ENTX /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -1.38% -18.81% +17.43 ENTX /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin ACTIVE -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) -65.00% 35.80% -100.80 DBVT /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 2.37 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 3/9 -1.00 DBVT /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 62.1 42.1 +20.00 ENTX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $556.6M $596.7M -$40.2M DBVT /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ENTX REV DBVT REV ENTX GROSS % DBVT GROSS % ENTX FCF DBVT FCF
FY 2025 $42.0K $5.6M 0.0% — -$7.5M -$121.7M
FY 2024 $181.0K $4.2M 5.0% — -$6.8M -$106.8M
FY 2023 $24.9M $15.7M — — -$7.3M -$79.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ENTX // BETA —
DBVT // BETA —